Literature DB >> 21437742

Clinical features and pedigree report of a patient with giant neurofibroma.

Jianda Zhou1, Zizi Chen, Wanmeng Li, Chengqun Luo, Chaoqi Ying, Ping Li, Jia Chen.   

Abstract

Neurofibromatosis (NF) is a genetically inherited, autosomal-dominant disease with an incidence of 1/3,000 in live births. There are two types of NF, NF 1 and NF 2, and NF 1 is the most common type. This study reports on the diagnosis, treatment, and related family medical history of a rare case with NF-1 in the right lower leg.

Entities:  

Mesh:

Year:  2011        PMID: 21437742     DOI: 10.1007/s12032-011-9882-3

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  5 in total

1.  First giant gluteal neurofibroma reported in the literature in a person with haemophilia and its high risk of massive bleeding to death.

Authors:  J Fernandez-Delgado; E C Rodriguez-Merchan; J R Martinez-Mendez
Journal:  Haemophilia       Date:  2005-07       Impact factor: 4.287

Review 2.  Neurofibromatosis type 1. I. General overview.

Authors:  M M Lakkis; G I Tennekoon
Journal:  J Neurosci Res       Date:  2000-12-15       Impact factor: 4.164

Review 3.  Plexiform neurofibromas.

Authors:  B R Korf
Journal:  Am J Med Genet       Date:  1999-03-26

4.  Evaluation of plexiform neurofibroma in neurofibromatosis type 1 in 18 family members of 3 generations: ultrasonography and magnetic resonance imaging a diagnostic supplement.

Authors:  Virendra N Sehgal; Sonal Sharma; Rakesh Oberai
Journal:  Int J Dermatol       Date:  2009-03       Impact factor: 2.736

5.  Atypical neurofibroma of the skin and subcutaneous tissue: clinicopathologic analysis of 11 cases.

Authors:  Chris H Jokinen; Zsolt B Argenyi
Journal:  J Cutan Pathol       Date:  2009-03-25       Impact factor: 1.587

  5 in total
  1 in total

1.  Surgically treated solitary giant gluteal and retroperitoneal neurofibroma: a case report.

Authors:  Xiang-qian Shen; Hui Shen; Shou-cheng Wu; Ying Lv; Hui Lu; Xiang-jin Lin
Journal:  World J Surg Oncol       Date:  2016-04-27       Impact factor: 2.754

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.